Mtl1 Leucoflex Drug Interactions: 68 Major, 803 Moderate
Mtl1 Leucoflex (Anticoagulant Citrate Phosphate Dextrose Solution With As-1) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Mtl1 Leucoflex. Always confirm against the full prescribing information.
100 interactions
Abacavir
The metabolism of Abacavir can be decreased when combined with Adenine.
Level 2 evidence
Abemaciclib
The serum concentration of Abemaciclib can be increased when it is combined with Mannitol.
Level 2 evidence
Abrocitinib
The serum concentration of Mannitol can be increased when it is combined with Abrocitinib.
Level 2 evidence
Acebutolol
Sodium phosphate, monobasic may increase the hyperkalemic activities of Acebutolol.
Level 2 evidence
Aceclofenac
The risk or severity of bleeding and hemorrhage can be increased when Aceclofenac is combined with Sodium citrate.
Level 1 evidence
Aceclofenac
The risk or severity of renal failure can be increased when Sodium phosphate, monobasic is combined with Aceclofenac.
Level 2 evidence
Acenocoumarol
The risk or severity of bleeding can be increased when Acenocoumarol is combined with Sodium citrate.
Level 2 evidence
Acetaminophen
The metabolism of Acetaminophen can be decreased when combined with Adenine.
Level 2 evidence
Acetazolamide
Acetazolamide may increase the nephrotoxic activities of Sodium phosphate, monobasic.
Level 2 evidence
Acetazolamide
The risk or severity of dehydration can be increased when Acetazolamide is combined with Mannitol.
Level 2 evidence
Acetylsalicylic acid
Acetylsalicylic acid may increase the anticoagulant activities of Sodium citrate.
Level 1 evidence
Acetylsalicylic acid
Acetylsalicylic acid may decrease the excretion rate of Mannitol which could result in a higher serum level.
Level 1 evidence
Acetylsalicylic acid
The risk or severity of renal failure can be increased when Sodium phosphate, monobasic is combined with Acetylsalicylic acid.
Level 2 evidence
Enter your NPI to unlock 8 major interactions for Mtl1 Leucoflex
Mtl1 Leucoflex (Anticoagulant Citrate Phosphate Dextrose Solution With As-1) has 1733 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Mtl1 Leucoflex (Anticoagulant Citrate Phosphate Dextrose Solution With As-1) has 68 major, 803 moderate, and 862 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Mtl1 Leucoflex. Always confirm against the full prescribing information.